- Home
- ASPI vs SMTI Comparison
ASPI vs SMTI Comparison
Compare ASPI & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPI
- SMTI
- Stock Information
- Founded
- ASPI 2021
- SMTI 1982
- Country
- ASPI United States
- SMTI United States
- Employees
- ASPI N/A
- SMTI N/A
- Industry
- ASPI Major Chemicals
- SMTI Medical/Dental Instruments
- Sector
- ASPI Industrials
- SMTI Health Care
- Exchange
- ASPI Nasdaq
- SMTI Nasdaq
- Market Cap
- ASPI 357.0M
- SMTI 288.2M
- IPO Year
- ASPI 2022
- SMTI N/A
- Fundamental
- Price
- ASPI $4.89
- SMTI $33.01
- Analyst Decision
- ASPI Strong Buy
- SMTI Buy
- Analyst Count
- ASPI 2
- SMTI 1
- Target Price
- ASPI $4.50
- SMTI $44.00
- AVG Volume (30 Days)
- ASPI 5.7M
- SMTI 36.4K
- Earning Date
- ASPI 11-19-2024
- SMTI 11-12-2024
- Dividend Yield
- ASPI N/A
- SMTI N/A
- EPS Growth
- ASPI N/A
- SMTI N/A
- EPS
- ASPI N/A
- SMTI N/A
- Revenue
- ASPI $3,383,374.00
- SMTI $78,056,873.00
- Revenue This Year
- ASPI $1,760.86
- SMTI $29.95
- Revenue Next Year
- ASPI $314.74
- SMTI $19.68
- P/E Ratio
- ASPI N/A
- SMTI N/A
- Revenue Growth
- ASPI N/A
- SMTI 24.66
- 52 Week Low
- ASPI $1.65
- SMTI $26.00
- 52 Week High
- ASPI $9.33
- SMTI $43.25
- Technical
- Relative Strength Index (RSI)
- ASPI 46.16
- SMTI 34.95
- Support Level
- ASPI $4.30
- SMTI $31.13
- Resistance Level
- ASPI $6.01
- SMTI $34.22
- Average True Range (ATR)
- ASPI 0.57
- SMTI 1.80
- MACD
- ASPI -0.02
- SMTI -0.63
- Stochastic Oscillator
- ASPI 42.86
- SMTI 12.98
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.